相关实验视频

Updated: Jun 21, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

[膜软部肉瘤 - - 由融合基因产物调节的血管生成机制]

Takuro Nakamura¹, Miwa Tanaka

¹Dept. of Experimental Pathology, Institute of Medical Science, Tokyo Medical University.

Gan to kagaku ryoho. Cancer & chemotherapy

|July 15, 2024

概括

膜软部肉瘤 (ASPS) 是一种罕见的癌症. 研究人员创建了一个小鼠模型,揭示了ASPSCR1-TFE3融合基因通过影响血管形成来驱动瘤生长和转移.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

膜软部肉瘤 (ASPS) 是一种罕见的恶性瘤,影响年轻人,其特点是密集的血管网络和频繁的转移.
由t(X;17) 转位产生的ASPSCR1-TFE3融合基因是ASPS的决定性基因变异,导致异常的转录调节.

研究的目的:

开发和描述ASPS的新型小鼠模型,以调查其潜在的生物机制.
确定关键的分子途径和涉及ASPS病变的遗传标,特别关注瘤血管生成和转移.

主要方法:

通过将ASPSCR1-TFE3融合基因引入小鼠胚胎介质细胞,生成小鼠模型.
利用表观遗传CRISPR查来识别血管生成相关增强剂和向基因.
在开发的小鼠模型中分析了瘤血管生成,血管结构和转移过程.

主要成果:

鼠标模型成功地回顾了人类ASPS的关键特征,包括膜结构和丰富的血管系统.
发现ASPSCR1-TFE3与活性增强剂相关,其损失减少了血管生成相关增强剂.
这项研究确定了Rab27a和Sytl2作为关键基因,促进血管生成因子 (Pdgfb,Vwf) 的运输,导致ASPS的特征性血管结构.

结论:

ASPSCR1-TFE3融合基因通过调节特定的增强剂和基因,在驱动ASPS瘤血管生成和转移方面发挥着关键作用.
Rab27/Sytl轴被确定为ASPS病变发生的重要途径,代表了这种罕见癌症的潜在新疗法标.

更多相关视频

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

相关概念视频

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...